[1]
Dutta, A. , Satapathy, T. and Sahu, P. 2026. EXPLOITING RECEPTOR NANOCLUSTERS TO BIAS CLATHRIN VS. CAVEOLIN UPTAKE: MOLECULAR DESIGN RULES FOR TARGETED ANTI-CANCER NANOMEDICINES. Journal of Applied Pharmacology and Toxicology. 2, 1 (Jun. 2026), 17–49. DOI:https://doi.org/10.69857/joapt.v2i1.40.